Recent studies have recognized liver-infiltrating immune cells, including regulatory T (Treg) cells and effector T cells (such as CD4+ T cells and CD8+ T cells), as potential prognostic factors in HCC patients (20–22). Here, CD8A is linked to hepatocellular carcinoma.